Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-08-01
DOI
10.1093/jac/dkz369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Semi-mechanistic pharmacokinetic–pharmacodynamic modelling of antibiotic drug combinations
- (2018) M.J.E. Brill et al. CLINICAL MICROBIOLOGY AND INFECTION
- Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations
- (2018) Robin J Svensson et al. JOURNAL OF INFECTIOUS DISEASES
- The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model
- (2017) Chunli Chen et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Antibiotic tolerance facilitates the evolution of resistance
- (2017) Irit Levin-Reisman et al. SCIENCE
- A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions
- (2017) Sebastian G. Wicha et al. Nature Communications
- A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action
- (2016) Charlotte Louise Hendon-Dunn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Distinguishing between resistance, tolerance and persistence to antibiotic treatment
- (2016) Asher Brauner et al. NATURE REVIEWS MICROBIOLOGY
- Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic Modeling
- (2016) Matthieu Jacobs et al. PLoS Computational Biology
- Novel Approach To Optimize Synergistic Carbapenem-Aminoglycoside Combinations against Carbapenem-Resistant Acinetobacter baumannii
- (2015) Rajbharan Yadav et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience
- (2015) Marco Cavaleri et al. CLINICAL INFECTIOUS DISEASES
- A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effectsin vitro
- (2015) Oskar Clewe et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents
- (2014) Suresh B. Lakshminarayana et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing
- (2014) A. F. Mohamed et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
- (2014) Corinne S. Merle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis
- (2014) George L. Drusano et al. PLoS One
- Quantifying Subpopulation Synergy for Antibiotic Combinations via Mechanism-Based Modeling and a Sequential Dosing Design
- (2013) Cornelia B. Landersdorfer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic Mismatch Does Not Lead to Emergence of Isoniazid- or Rifampin-Resistant Mycobacterium tuberculosis but to Better Antimicrobial Effect: a New Paradigm for Antituberculosis Drug Scheduling
- (2011) Shashikant Srivastava et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model
- (2010) J. B. Bulitta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started